Resolvin E1, an endogenous lipid mediator derived from eicosapentaenoic acid, prevents dextran sulfate sodium–induced colitis
Inflammatory Bowel Diseases2009Vol. 16(1), pp. 87–95
Citations Over TimeTop 10% of 2009 papers
Tsukasa Ishida, Masaru Yoshida, Makoto Arita, Yosuke Nishitani, Shin Nishiumi, Atsuhiro Masuda, Shigeto Mizuno, Tetsuya Takagawa, Yoshinori Morita, Hiromu Kutsumi, Hideto Inokuchi, Charles N. Serhan, Richard S. Blumberg, Takeshi Azuma
Abstract
These results indicate that RvE1 suppresses proinflammatory responses of macrophages. RvE1 and its receptor may therefore be useful as therapeutic targets in the treatment of human inflammatory bowel disease and other inflammatory disorders.
Related Papers
- → Adaptation to bacterial lipopolysaccharide controls lipopolysaccharide-induced tumor necrosis factor production in rabbit macrophages.(1990)206 cited
- → Participation of tumor necrosis factor in the mediation of gram negative bacterial lipopolysaccharide-induced injury in rabbits.(1988)594 cited
- → Alcohol suppresses lipopolysaccharide-induced tumor necrosis factor activity in serum and lung(1989)112 cited
- → Tumor Necrosis Factor Alone Does Not Explain the Lethal Effect of Lipopolysaccharide(1991)25 cited
- → Requirement for the continual presence of lipopolysaccharide for production of tumor necrosis factor by thioglycollate‐induced peritoneal murine macrophages(1986)52 cited